Severe hypersensitivity reactions to 2 immunotherapy agents in a patient with cutaneous squamous cell carcinoma

A patient with metastatic cutaneous squamous cell carcinoma developed a severe hypersensitivity reaction to pembrolizumab and subsequently to cemiplimab, despite premedication.

Authors

Institutions

Publication Details

Journal
American Journal of Health-System Pharmacy
Published
2024-10-19
DOI
https://doi.org/10.1093/ajhp/zxae286
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe hypersensitivity reactions to 2 immunotherapy agents in a patient with cutaneous squamous cell carcinoma

Justin Liauw, S Almeida da Silveira, Iole Ribizzi-Akthar
1 citations
American Journal of Health-System Pharmacy
Cancer Immunotherapy and Biomarkers
0.28
article

Severe hypersensitivity reactions to 2 immunotherapy agents in a patient with cutaneous squamous cell carcinoma

Justin Liauw, S Almeida da Silveira, Iole Ribizzi-Akthar
article en
1 citations

Abstract

A patient with metastatic cutaneous squamous cell carcinoma developed a severe hypersensitivity reaction to pembrolizumab and subsequently to cemiplimab, despite premedication.

American Journal of Health-System PharmacyVol. 82(5)
Providence College (US), Brown University (US), Rhode Island Hospital (US), Lifespan (US)
Good health and well-being
Openalex Percentile: Top 35%
Cancer Immunotherapy and Biomarkers
0.28
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.